StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JUGI.L$324.50+0.15%
Fair $324.50+0.0%

JUGI.L

JPMorgan UK Small Cap Growth & Income

Unknown / UnknownLSE

$324.50

+0.50 (+0.15%)

Fairly Valued+0.0%Fair Value $324.50Fund rank 28/100 · Data gapFallback financials|
SA 32/D
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $6.2M · quality 45.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 30/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · JUGI.LLocal privado en este navegador · JPMorgan UK Small Cap Growth & Income
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$400M

P/E

7.7x

↓

EV/EBITDA

N/A

•

ROE

19.3%

↑

Gross Margin

N/A

•

Debt/Equity

0.11

↓
52-Week Range$325
$288$360

TradingView lightweight chart

JUGI.L price, volumen y niveles de valoración

Último $324.50Periodo +450.9%
Fair value: $324.50

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

-10.5%

FCF CAGR

+105.4%

FCF margin

13.6%

FCF / Net income

0.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $101.3M · net income $99.7M · FCF $13.8M

2021-FY → 2024-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

98.4%-1.2% pts

FCF margin

13.6%+12.5% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$101.3M$101.3M$-12.3M$-80.7M$141.1M
Net Income$99.7M$99.7M$-12.9M$-81.4M$140.6M
EPS0.970.97-0.16-1.041.80
Net Margin98.4%98.4%104.9%100.8%99.7%
Balance Sheet
Debt/Equity0.110.110.110.100.10
Cash Flow
Free Cash Flow$13.8M$13.8M$6.2M$4.4M$1.6M
Returns
ROE19.3%19.3%-5.3%-31.3%40.6%
Valuation
P/E7.737.73——233.63
P/B64.7464.7487.9889.4694.89
Growth & Yield
Revenue Growth926.6%926.6%84.8%-157.2%—
EPS Growth686.8%686.8%84.2%-157.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

210.0%

muy exigente

EPS terminal req.

$28.79

Spread vs growth

476.8%

5Y implied EPS CAGR

104.8%

muy exigente

EPS terminal req.

$34.84

Spread vs growth

582.0%

10Y implied EPS CAGR

50.1%

muy exigente

EPS terminal req.

$56.11

Spread vs growth

636.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -1.7%

Total return

-1.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.16 → 0.97

Residual

-1.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-1.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.